Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain

Clinical Journal of Pain

Volumn 25, Issue 7, 2009, Pages 562-569

  Chen, Jen Yin ^a   Chang, Chia Yu ^a,b   Feng, Ping Hsun ^a   Chu, Chin Chen ^a   So, Edmund Cheng ^a   Hu, Miao Lin ^c  

^a Chi Mei Foundation Hospital   (Taiwan)

^b SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Brush evoked pain; Mechanism based; Postherpetic neuralgia; Spontaneous pain; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; STIMULATION; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 70350739120     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318193cf32     Document Type: Article

References (37)

1. Bowsher D. Post-herpetic neuralgia in older patients. Incidence and optimal treatment. Drugs Aging. 1994;5:411-418.
2. Dworkin RH, Carrington D, Cunningham A, et al. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res. 1997;33:73-85. (Pubitemid 27047516)
3. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symp-toms, mechanisms, and management. Lancet. 1999;353: 1959-1964.
4. Pappagallo M, Oaklander AL, Quatrano-Piacentini AL, et al. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology. 2000;92:691-698. (Pubitemid 30130172)
5. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis. 1998;5:209-227. (Pubitemid 28519152)
6. Levine M, Dhariwal KR, Washko PW, et al. Ascorbic acid and in situ kinetics: a new approach to vitamin requirements. Am J Clin Nutr. 1991;54:1157S-1162S.
7. Thomas SL, Wheeler JG, Hall AJ. Micronutrient intake and the risk of herpes zoster: a case-control study. Int J Epidemiol. 2006;35:307-314.
8. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63: 760-765. (Pubitemid 26126597)
9. Chen JY, Chu CC, So EC, et al. Treatment of postherpetic neuralgia with intravenous administration of vitamin C. Anesth Analg. 2006;103:1616-1617. (Pubitemid 44949286)
10. Zollinger PE, Tuinebreijer WE, Kreis RW, et al. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial. Lancet. 1999;354: 2025-2028.
11. Zollinger PE, Tuinebreijer WE, Breederveld RS, et al. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am. 2007;89: 1424-1431. (Pubitemid 47041516)
12. Yang Z, Copolov DL, Lim AT. Ascorbic acid augments the adenylyl cyclase-c AMP system mediated POMC m RNA expression and beta-endorphin secretion from hypothalamic neurons in culture. Brain Res. 1996;706:243-248. (Pubitemid 26048682)
13. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmaco-kinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-537.
14. Farrar JT, Young JP Jr, La Moreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11- pointnumericalpainratingscale. Pain. 2001;94:149-158. (Pubitemid 33016608)
15. Berger L, Gerson CD, Yu TF. The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med. 1977;62:71-76. (Pubitemid 8025540)
16. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial Alzheimer's Disease Cooperative Study. JAMA. 2000;283:1007-1015. (Pubitemid 30112214)
17. Rosenstock J, Tuchman M, La Moreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110: 628-638. (Pubitemid 39036794)
18. Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004; 8:283-291. (Pubitemid 38859657)
19. Chung WY, Chung JK, Szeto YT, et al. Plasma ascorbic acid: measurement, stability and clinical utility revisited. Clin Biochem. 2001;34:623-627. (Pubitemid 34159352)
20. Key T, Oakes S, Davey G, et al. Stability ofvitamins A, C, and E, carotenoids, lipids, and testosterone in whole blood stored at 4 degrees C for 6 and 24 hours before separation of serum and plasma. Cancer Epidemiol Biomarkers Prev. 1996;5: 811-814. (Pubitemid 26346280)
21. Lee W, Roberts SM, Labbe RF. Ascorbic acid determination with an automated enzymatic procedure. Clin Chem. 1997;43:154-157. (Pubitemid 27024406)
22. Ihara H, Matsumoto N, Shino Y, et al. An automated assay for measuring serum ascorbic acid with use of 4-hydroxy-2,2, 6,6-tetramethylpiperidinyloxy, free radical and o-phenylene-diamine. Clin Chim Acta. 2000;301:193-204.
23. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350-354. (Pubitemid 35291575)
24. Vander Jagt DJ, Garry PJ, Bhagavan HN. Ascorbic acid intake and plasma levels in healthy elderly people. Am J Clin Nutr. 1987;46:290-294. (Pubitemid 17118906)
25. Tallaksen CM, Bohmer T, Bell H. Concentrations of the water-soluble vitamins thiamin, ascorbic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals. Am J Clin Nutr. 1992;56:559-564.
26. Barabas J, Nagy E, Degrell I. Ascorbic acid in cerebrospinal fluid-a possible protection against free radicals in the brain. Arch Gerontol Geriatr. 1995;21:43-48.
27. Brill S, Sedgwick PM, Hamann W, et al. Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth. 2002;89:711-714. (Pubitemid 35277219)
28. Gottrup H, Bach FW, Juhl G, et al. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology. 2006;104:527-536.
29. Kim HK, Park SK, Zhou JL, et al. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain. 2004;111:116-124. (Pubitemid 39141013)
30. Sweitzer SM, Hickey WF, Rutkowski MD, et al. Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain. 2002;100:163-170. (Pubitemid 35305133)
31. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci. 2006;101: 107-117. (Pubitemid 43938761)
32. Wu CM, Lin MW, Cheng JT, et al. Regulated, electropora-tion-mediated delivery of pro-opiomelanocortin gene sup-presses chronic constriction injury-induced neuropathic pain in rats. Gene Ther. 2004;11:933-940.
33. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000;23:209-216. (Pubitemid 30236180)
34. Lonnrot K, Metsa-Ketela T, Molnar G, et al. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic Biol Med. 1996;21:211-217. (Pubitemid 26249607)
35. Gradl G, Gaida S, Finke B, et al. Exaggeration of tissue trauma induces signs and symptoms of acute CRPS I, however displays distinct differences to experimental CRPS II. Neurosci Lett. 2006;402:267-272. (Pubitemid 43850160)
36. Djouhri L, Koutsikou S, Fang X, et al. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci. 2006;26:1281-1292. (Pubitemid 43239574)
37. Rowbotham MC. Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology. 2005; 65:S66-S73.